نتائج البحث - von Eynatten, Maximilian

Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials حسب von Eynatten, Maximilian, Gong, Yan, Emser, Angela, Woerle, Hans-Juergen

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Blood glucose, diabetes and metabolic control in patients with community-acquired pneumonia حسب Lepper, Philipp M., Bals, Robert, Jüni, Peter, von Eynatten, Maximilian

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme حسب Johansen, Odd Erik, Neubacher, Dietmar, von Eynatten, Maximilian, Patel, Sanjay, Woerle, Hans-Juergen

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Empagliflozin Induces Transient Diuresis Without Changing Long-Term Overall Fluid Balance in Japanese Patients With Type 2 Diabetes حسب Yasui, Atsutaka, Lee, Ganghyuck, Hirase, Tetsuaki, Kaneko, Tatsuroh, Kaspers, Stefan, von Eynatten, Maximilian, Okamura, Tomoo

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction حسب Groop, Per-Henrik, Cooper, Mark E., Perkovic, Vlado, Emser, Angela, Woerle, Hans-Juergen, von Eynatten, Maximilian

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials حسب Davidson, Jaime A, Lajara, Rosemarie, Aguilar, Richard B, Mattheus, Michaela, Woerle, Hans-Juergen, von Eynatten, Maximilian

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA‐REG OUTCOME(®) trial حسب Kadowaki, Takashi, Nangaku, Masaomi, Hantel, Stefan, Okamura, Tomoo, von Eynatten, Maximilian, Wanner, Christoph, Koitka‐Weber, Audrey

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Altered Molecular Weight Forms of Adiponectin in Hypertension حسب Baumann, Marcus, Von Eynatten, Maximilian, Dan, Liu, Richart, Tom, Kouznetsova, Tatiana, Heemann, Uwe, Staessen, Jan A.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study حسب McGill, Janet B., Sloan, Lance, Newman, Jennifer, Patel, Sanjay, Sauce, Christophe, von Eynatten, Maximilian, Woerle, Hans-Juergen

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and micro... حسب Jax, Thomas, Stirban, Alin, Terjung, Arne, Esmaeili, Habib, Berk, Andreas, Thiemann, Sandra, Chilton, Robert, von Eynatten, Maximilian, Marx, Nikolaus

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Multinational Trial حسب Levin, Adeera, Perkovic, Vlado, Wheeler, David C., Hantel, Stefan, George, Jyothis T., von Eynatten, Maximilian, Koitka-Weber, Audrey, Wanner, Christoph

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes حسب Bjornstad, Petter, Laffel, Lori, Tamborlane, William V., Simons, Gudrun, Hantel, Stefan, von Eynatten, Maximilian, George, Jyothis, Marquard, Jan, Cherney, David Z.I.

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Associations of Fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy حسب Roos, Marcel, Oikonomou, Dimitrios, von Eynatten, Maximilian, Luppa, Peter B, Heemann, Uwe, Lutz, Jens, Baumann, Marcus, Nawroth, Peter P, Bierhaus, Angelika, Humpert, Per M

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus حسب Cherney, David ZI, Perkins, Bruce A, Soleymanlou, Nima, Har, Ronnie, Fagan, Nora, Johansen, Odd Erik, Woerle, Hans-Juergen, von Eynatten, Maximilian, Broedl, Uli C

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin–angiotensin system inhibitors in type 2 diabetic patients with albuminuria حسب Cooper, Mark E., Perkovic, Vlado, Groop, Per-Henrik, Hocher, Berthold, Hehnke, Uwe, Meinicke, Thomas, Koitka-Weber, Audrey, van der Walt, Sandra, von Eynatten, Maximilian

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Nephrotic-range proteinuria in type 2 diabetes: Effects of empagliflozin on kidney disease progression and clinical outcomes حسب Ruggenenti, Piero, Kraus, Bettina J., Inzucchi, Silvio E., Zinman, Bernard, Hantel, Stefan, Mattheus, Michaela, von Eynatten, Maximilian, Remuzzi, Giuseppe, Koitka-Weber, Audrey, Wanner, Christoph

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study حسب Herrington, William G, Preiss, David, Haynes, Richard, von Eynatten, Maximilian, Staplin, Natalie, Hauske, Sibylle J, George, Jyothis T, Green, Jennifer B, Landray, Martin J, Baigent, Colin, Wanner, Christoph

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study حسب Herrington, William G, Preiss, David, Haynes, Richard, von Eynatten, Maximilian, Staplin, Natalie, Hauske, Sibylle J, George, Jyothis T, Green, Jennifer B, Landray, Martin J, Baigent, Colin, Wanner, Christoph

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damag... حسب Lizzo, Giulia, Migliavacca, Eugenia, Lamers, Daniela, Frézal, Adrien, Corthesy, John, Vinyes-Parès, Gerard, Bosco, Nabil, Karagounis, Leonidas G., Hövelmann, Ulrike, Heise, Tim, von Eynatten, Maximilian, Gut, Philipp

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل

Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study حسب Lepper, Philipp M, Ott, Sebastian, Nüesch, Eveline, von Eynatten, Maximilian, Schumann, Christian, Pletz, Mathias W, Mealing, Nicole M, Welte, Tobias, Bauer, Torsten T, Suttorp, Norbert, Jüni, Peter, Bals, Robert, Rohde, Gernot

احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل